Pharmaceutical Industry Role tackles the complex issue of antibiotic resistance, examining the pharmaceutical industry's often-overlooked influence. It highlights how economic incentives can disincentivize new antibiotic development, leading companies to prioritize other drugs. The book also investigates how pharmaceutical manufacturing practices contribute to environmental contamination and, subsequently, the spread of drug-resistant bacteria, demonstrating the intersection of business practices and public health.
This book uniquely connects macro-level industry forces with the micro-level consequences of antibiotic resistance, moving beyond individual blame to analyze systemic factors. It begins by defining antibiotic resistance and its implications, then explores the industry's role, including the economics of antibiotic development and the impact of manufacturing processes. Analysis of wastewater antibiotic levels near manufacturing plants is included.
The book progresses to explore potential solutions, such as policy recommendations and incentives for responsible practices. By combining business, public health, and environmental science perspectives, Pharmaceutical Industry Role provides a comprehensive understanding of this critical issue, making it valuable for policymakers, public health professionals, and anyone interested in the future of antibiotic therapy.
